Clinical Trial Update: Axitinib as Maintenance Treatment in Patients With Metastatic CRC [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating axitinib as maintenance therapy for metastatic colorectal cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Axitinib (Axitinib)

Snippet

Sponsor: Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) | Conditions: Colorectal Carcinoma | Phase 2 | Status: TERMINATED